While CSN5 was recently shown to be a critical link between inflammation and cancer progression, Juergen Bernhagen (Germany) highlighted an atheroprotective role of CSN5 through modulating the NF-κB immune response pathway. The gene discussed is COPS5; the disease is cancer.